Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 50,000 shares at $62.00 ($3.1M) on 2021-02-09, disclosed to the SEC on 2021-02-10.
Open-market sale of $3.1M ATRC by President, CEO, & Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.00 | 25,000 | $1.5M | 49.6% |
| 2 | $62.00 | 25,000 | $1.6M | 50.4% |
| Total | $61.50 avg | 50,000 | $3.1M | 100% |
| Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |
| ATRC | SELL | 2020-12-23 | $4.2M | — | Filing → |